TP53 and rheumatoid arthritis: Previous studies showed that E2F1 was significantly downregulated in RA, and overexpression of E2F1 suppressed the proliferation and invasion of FLS and pro-inflammatory cytokines production via p53 signaling pathway in RA [27].